0.39
1.22%
0.0047
アフターアワーズ:
.40
0.01
+2.56%
前日終値:
$0.3853
開ける:
$0.3827
24時間の取引高:
640.17K
Relative Volume:
0.61
時価総額:
$46.59M
収益:
-
当期純損益:
$-225.14M
株価収益率:
-0.199
EPS:
-1.96
ネットキャッシュフロー:
$-192.27M
1週間 パフォーマンス:
-6.77%
1か月 パフォーマンス:
-15.51%
6か月 パフォーマンス:
-67.23%
1年 パフォーマンス:
-92.11%
Invivyd Inc Stock (IVVD) Company Profile
IVVD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
0.39 | 46.59M | 0 | -225.14M | -192.27M | -1.96 |
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-04-05 | アップグレード | Guggenheim | Neutral → Buy |
2024-03-26 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2023-12-19 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
2023-05-01 | 開始されました | H.C. Wainwright | Buy |
Invivyd Inc (IVVD) 最新ニュース
Invivyd Inc (IVVD) Volatility Hits 11.66% – Here Is What You Should Do - Stocks Register
We Might See A Profit From Invivyd, Inc. (NASDAQ:IVVD) Soon - Yahoo Finance
Invivyd seeks FDA nod for COVID-19 treatment in immunocompromised - MSN
Invivyd’s (IVVD) Buy Rating Reaffirmed at D. Boral Capital - Defense World
Invivyd's (IVVD) Buy Rating Reiterated at D. Boral Capital - MarketBeat
Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA's Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mild-to-Moderate COVID-19 in Certain Immunocompromi - The Manila Times
Invivyd, Inc. (NASDAQ:IVVD) Shares Bought by Barclays PLC - Defense World
Invivyd, Inc. (NASDAQ:IVVD) Sees Large Increase in Short Interest - Defense World
Invivyd (NASDAQ:IVVD) vs. iTeos Therapeutics (NASDAQ:ITOS) Head-To-Head Comparison - Defense World
D. Boral Capital Reiterates Buy Rating for Invivyd (NASDAQ:IVVD) - Defense World
What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday? - Yahoo Finance
Invivyd (NASDAQ:IVVD) Receives "Buy" Rating from D. Boral Capital - MarketBeat
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC - The Manila Times
Invivyd's PEMGARDA Shows Powerful Defense Against Dominant COVID Variant XEC in Latest Data - StockTitan
Barclays PLC Raises Stake in Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Why Invivyd, Inc. (IVVD) Is Among the Best Penny Stocks to Invest In According to Media? - Yahoo Finance
12 Best Penny Stocks to Invest in According to the Media - Insider Monkey
State Street Corp Increases Position in Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Invivyd Inc (NASDAQ: IVVD): A Blank Check? - Stocks Register
Invivyd director Terrance McGuire sells stock worth $131,528 By Investing.com - Investing.com Nigeria
Insider Selling: Invivyd, Inc. (NASDAQ:IVVD) Director Sells 86,545 Shares of Stock - MarketBeat
Invivyd director Terrance McGuire sells stock worth $131,528 - Investing.com India
Invivyd faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria
Invivyd faces Nasdaq delisting over share price rule - Investing.com
Terrance Mcguire Sells 119,805 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat
Terrance Mcguire Sells 83,817 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat
Terrance Mcguire Sells 75,776 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat
Invivyd director Terrance McGuire sells $164,867 in stock By Investing.com - Investing.com Nigeria
Invivyd director Terrance McGuire sells $164,867 in stock - Investing.com India
Charles Schwab Investment Management Inc. Sells 289,312 Shares of Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Insider Selling: Invivyd, Inc. (NASDAQ:IVVD) Director Sells 74,764 Shares of Stock - MarketBeat
Invivyd director Terrance McGuire sells shares worth $147,795 By Investing.com - Investing.com South Africa
Invivyd director Terrance McGuire sells shares worth $147,795 - Investing.com
Invivyd, Inc. (NASDAQ:IVVD) Director Sells $30,718.73 in Stock - MarketBeat
Invivyd director Terrance McGuire sells $103,384 in stock - Investing.com
Invivyd director Terrance McGuire sells $103,384 in stock By Investing.com - Investing.com South Africa
Adagio Therapeutics Stock Hits 52-Week Low at $0.57 Amid Challenges - Investing.com
Fmr LLC Sells 1,046,775 Shares of Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Fmr LLC Decreases Stock Holdings in Invivyd, Inc. (NASDAQ:IVVD) - MarketBeat
Invivyd announces board member resignation By Investing.com - Investing.com South Africa
Invivyd announces board member resignation - Investing.com
Analysts Provide An Important Insights On Invivyd Inc (IVVD) - Stocks Register
Invivyd's (IVVD) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
HC Wainwright Cuts Invivyd (NASDAQ:IVVD) Price Target to $10.00 - Defense World
FY2024 Earnings Forecast for Invivyd Issued By HC Wainwright - Defense World
Invivyd Inc (IVVD) 財務データ
収益
当期純利益
現金流量
EPS
Invivyd Inc (IVVD) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
MCGUIRE TERRANCE | Director |
Dec 27 '24 |
Sale |
0.52 |
83,744 |
43,647 |
3,256,776 |
MCGUIRE TERRANCE | Director |
Dec 30 '24 |
Sale |
0.48 |
86,545 |
41,784 |
3,170,231 |
MCGUIRE TERRANCE | Director |
Dec 20 '24 |
Sale |
0.42 |
119,805 |
50,725 |
3,568,274 |
MCGUIRE TERRANCE | Director |
Dec 26 '24 |
Sale |
0.54 |
83,817 |
45,563 |
3,340,520 |
MCGUIRE TERRANCE | Director |
Dec 24 '24 |
Sale |
0.51 |
68,161 |
34,503 |
3,424,337 |
MCGUIRE TERRANCE | Director |
Dec 23 '24 |
Sale |
0.45 |
75,776 |
34,076 |
3,492,498 |
大文字化:
|
ボリューム (24 時間):